Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

ClinicalTrials.gov ID: NCT04301843

Public ClinicalTrials.gov record NCT04301843. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

Study identification

NCT ID
NCT04301843
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Giselle Sholler
Other
Enrollment
131 participants

Conditions and interventions

Conditions

Interventions

  • Eflornithine Drug

Drug

Eligibility (public fields only)

Age range
Up to 31 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 24, 2020
Primary completion
Sep 30, 2028
Completion
Sep 30, 2033
Last update posted
Jul 7, 2026

2020 – 2033

United States locations

U.S. sites
25
U.S. states
21
U.S. cities
25
Facility City State ZIP Site status
University of Alabama/Children's of Alabama Birmingham Alabama 35201
Arkansas Children's Hospital Little Rock Arkansas 72202
UCSF Benioff Children's Hospital Oakland Oakland California 94609
Rady Children's Hospital San Diego California 92123
Connecticut Children's Hospital Hartford Connecticut 06106
Arnold Palmer Hospital for Children Orlando Florida 32806
St. Joseph's Children's Hospital Tampa Florida 33614
Augusta University Health Augusta Georgia 30912
University of Iowa Iowa City Iowa 52242
Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine Louisville Kentucky 40201
Helen DeVos Children's Hospital Grand Rapids Michigan 49503
Children's Hospital and Clinics of Minnesota Minneapolis Minnesota 55404
Children's Mercy Hospitals and Clinics Kansas City Missouri 64108
Cardinal Glennon Children's Hospital St Louis Missouri 63104
Hackensack University Medical Center Hackensack New Jersey 07601
Levine Children's Hospital Charlotte North Carolina 28204
Cleveland Clinic Children's Cleveland Ohio 44195
Randall Children's Hospital Portland Oregon 97227
Penn State Milton S. Hershey Medical Center and Children's Hospital Hershey Pennsylvania 17033
Hasbro Children's Hospital Providence Rhode Island 02901
Medical University of South Carolina Charleston South Carolina 29425
Dell Children's Blood and Cancer Center Austin Texas 78723
Children's Medical Center Dallas Dallas Texas 75235
Children's Hospital of The King's Daughters Norfolk Virginia 23507
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04301843, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 7, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04301843 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →